2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: Regulus Therapeutics went up 120%; 89bio went up 85%; Chimerix gained 69% and ...

Chloroplasts—the "light power plants" of plant cells—are increasingly the focus of synthetic biology. These organelles house ...

You might also like Studio Ghibli and Japanese Game Publishers Demand OpenAI Stop Training Sora 2 on Their Content UPI Breaks Record with 20.7 Billion Transactions in October; Daily Transactions Cross ...

Tharimmune ( ($THAR) ) has shared an update. On November 3, 2025, Tharimmune, Inc. announced a private placement offering expected to raise ...

UD chemical engineer wins the AIChE Langer Prize for efforts to harness biology to manage plastic waste sustainably ...

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

CNW/ - Syantra, Inc., a biotechnology company revolutionizing cancer detection, and Alamo Breast Cancer Foundation (ABCF), a ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.

The UP Marine Science Institute opened the first metallomics facility in the Philippines last Wednesday, October 22, 2025.